Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $1.96 billion. The enterprise value is $1.92 billion.
| Market Cap | 1.96B |
| Enterprise Value | 1.92B |
Important Dates
The next estimated earnings date is Thursday, July 30, 2026, before market open.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 45.48 million shares outstanding. The number of shares has decreased by -0.59% in one year.
| Current Share Class | 45.48M |
| Shares Outstanding | 45.48M |
| Shares Change (YoY) | -0.59% |
| Shares Change (QoQ) | +2.19% |
| Owned by Insiders (%) | 2.71% |
| Owned by Institutions (%) | 99.72% |
| Float | 41.94M |
Valuation Ratios
The trailing PE ratio is 97.79 and the forward PE ratio is 23.08. Omnicell's PEG ratio is 0.78.
| PE Ratio | 97.79 |
| Forward PE | 23.08 |
| PS Ratio | 1.60 |
| Forward PS | 1.55 |
| PB Ratio | 1.56 |
| P/TBV Ratio | 6.50 |
| P/FCF Ratio | 17.51 |
| P/OCF Ratio | 12.55 |
| PEG Ratio | 0.78 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.08, with an EV/FCF ratio of 17.18.
| EV / Earnings | 93.96 |
| EV / Sales | 1.57 |
| EV / EBITDA | 26.08 |
| EV / EBIT | 47.83 |
| EV / FCF | 17.18 |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.50 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 2.42 |
| Debt / FCF | 1.81 |
| Interest Coverage | 9.25 |
Financial Efficiency
Return on equity (ROE) is 1.63% and return on invested capital (ROIC) is 1.77%.
| Return on Equity (ROE) | 1.63% |
| Return on Assets (ROA) | 1.21% |
| Return on Invested Capital (ROIC) | 1.77% |
| Return on Capital Employed (ROCE) | 2.64% |
| Weighted Average Cost of Capital (WACC) | 8.78% |
| Revenue Per Employee | $347,534 |
| Profits Per Employee | $5,797 |
| Employee Count | 3,525 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 7.22 |
Taxes
In the past 12 months, Omnicell has paid $17.33 million in taxes.
| Income Tax | 17.33M |
| Effective Tax Rate | 45.89% |
Stock Price Statistics
The stock price has increased by +43.77% in the last 52 weeks. The beta is 0.97, so Omnicell's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +43.77% |
| 50-Day Moving Average | 41.66 |
| 200-Day Moving Average | 39.11 |
| Relative Strength Index (RSI) | 61.05 |
| Average Volume (20 Days) | 782,057 |
Short Selling Information
The latest short interest is 3.16 million, so 6.94% of the outstanding shares have been sold short.
| Short Interest | 3.16M |
| Short Previous Month | 2.97M |
| Short % of Shares Out | 6.94% |
| Short % of Float | 7.53% |
| Short Ratio (days to cover) | 5.57 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.23 billion and earned $20.43 million in profits. Earnings per share was $0.44.
| Revenue | 1.23B |
| Gross Profit | 537.47M |
| Operating Income | 40.14M |
| Pretax Income | 37.76M |
| Net Income | 20.43M |
| EBITDA | 73.61M |
| EBIT | 40.14M |
| Earnings Per Share (EPS) | $0.44 |
Balance Sheet
The company has $239.22 million in cash and $202.18 million in debt, with a net cash position of $37.04 million or $0.81 per share.
| Cash & Cash Equivalents | 239.22M |
| Total Debt | 202.18M |
| Net Cash | 37.04M |
| Net Cash Per Share | $0.81 |
| Equity (Book Value) | 1.26B |
| Book Value Per Share | 27.63 |
| Working Capital | 239.25M |
Cash Flow
In the last 12 months, operating cash flow was $155.88 million and capital expenditures -$44.11 million, giving a free cash flow of $111.77 million.
| Operating Cash Flow | 155.88M |
| Capital Expenditures | -44.11M |
| Depreciation & Amortization | 33.47M |
| Net Borrowing | -175.00M |
| Free Cash Flow | 111.77M |
| FCF Per Share | $2.46 |
Margins
Gross margin is 43.87%, with operating and profit margins of 3.28% and 1.67%.
| Gross Margin | 43.87% |
| Operating Margin | 3.28% |
| Pretax Margin | 3.08% |
| Profit Margin | 1.67% |
| EBITDA Margin | 6.01% |
| EBIT Margin | 3.28% |
| FCF Margin | 9.12% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.59% |
| Shareholder Yield | 0.59% |
| Earnings Yield | 1.04% |
| FCF Yield | 5.71% |
Analyst Forecast
The average price target for Omnicell is $61.29, which is 42.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $61.29 |
| Price Target Difference | 42.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 5.28% |
| EPS Growth Forecast (3Y) | 12.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 2.37 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.37 |
| Piotroski F-Score | 7 |